PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26021F0164Ponatinib 15mg tab — Millennium Pharmaceuticals, Inc

Public-record facts for this award are shown above. Open SCOUT for live scoring relative to your firm, watchlists, and capture workflow.

260-Network Contract Office 20 (36C260)

Awarding office

Millennium Pharmaceuticals, Inc

Recipient

—

Estimated value

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract number36C26021F0164

Also listed as36C260-21-F-0164

Agency260-Network Contract Office 20 (36C260)

Awarding office260-Network Contract Office 20 (36C260)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentMillennium Pharmaceuticals, Inc

UEIENNFDLWFC6L1

PSC6505

Ponatinib 15MG Tab is a federal award for 260-Network Contract Office 20 (36C260) held by Millennium Pharmaceuticals, Inc. Estimated value —.

Ponatinib 15mg tab. Latest action is a modification.

Want the durability read on 36C26021F0164? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26021F0164?

36C26021F0164 (Ponatinib 15mg tab) is a 260-Network Contract Office 20 (36C260) award with an estimated value of —, currently held by Millennium Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C260-21-F-0164?

36C260-21-F-0164 is the dashed form of contract 36C26021F0164 (Ponatinib 15mg tab), held by Millennium Pharmaceuticals, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26021F0164?

260-Network Contract Office 20 (36C260) awarded 36C26021F0164 to Millennium Pharmaceuticals, Inc.

Who is the incumbent on 36C26021F0164?

Millennium Pharmaceuticals, Inc is the incumbent.

When does Millennium Pharmaceuticals, Inc’s 36C26021F0164 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C26021F0164? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by contract number; task orders appear as independent rows.